Cross-talk between EZH2 and NF-kB in breast cancers.
Epigenetic changes are reported to contribute to cancer progression. EZH2 is the catalytic component of PRC2 and its SET domain is involved in histone methyltransferase activity, to silence specific genes in cancer progression. Although EZH2 SET domain independent functions have been reported recent...
Saved in:
| Main Author: | |
|---|---|
| Other Authors: | |
| Format: | Final Year Project |
| Language: | English |
| Published: |
2010
|
| Subjects: | |
| Online Access: | http://hdl.handle.net/10356/38681 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Institution: | Nanyang Technological University |
| Language: | English |